Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF FEBRUARY 06, 2026 SAM #8838
SPECIAL NOTICE

65 -- Notice to Intent to Sole Source - Bio-Plex Reagents

Notice Date

2/4/2026 11:24:25 AM
 

Notice Type

Special Notice
 

NAICS

325414 — Biological Product (except Diagnostic) Manufacturing
 

Contracting Office

NATIONAL INSTITUTES OF HEALTH - CC BETHESDA MD 20892 USA
 

ZIP Code

20892
 

Solicitation Number

NOI-CC-26-002244
 

Response Due

2/14/2026 9:00:00 AM
 

Archive Date

03/01/2026
 

Small Business Set-Aside

NONE No Set aside used
 

Description

This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Bio-Rad Laboratories. Acquisition Description: The National Institutes of Health, Office of Purchasing and Contracts on behalf of The National Institutes of Health (NIH), Clinical Center (CC), Center for Cellular Engineering (CCE) has a need to approve a purchase order of Bio-Plex Pro Human Cytokine Screening Panel, 48-Plex kits from Bio-Rad, Bio-Plex Calibration kit and Validation kit, which will be used for our clinical CAR-T potency testing throughout development and manufacturing of CAR-T cells in PACT section of CCE. Description of Items: Key Features and Benefits for Bio-Plex Pro Human Cytokine Screening Panel, 48-Plex, calibration and validation kit as below: Designed for quantification of a panel of 48 cytokines, chemokines, and growth factors. Can be used for serum, plasma, culture supernatant, and many other sample types. Compiling profiles of a series of cytokine and Chemokine markers The assay panel provides more data from each sample. Save both money and time. These multiplex assays are highly suitable for researchers looking for predictive biomarkers using small sample volumes (12.5ul per well) The assay can be run in a significantly shorter time(~2hr) than conventional ELISA techniques. Ready to use validation and calibration kits with unique individual vials of each reagent. The period of performance for these products is three months: 5/1/2026-8/1/2026. The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-26-002244) by 12:00 PM eastern standard time on 02/14/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
 

Web Link

SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/c5fb624b9d1a4a0595fbfeb98a000de4/view)
 

Place of Performance

Address: Bethesda, MD 20892, USA

Zip Code: 20892

Country: USA
 

Record

SN07704459-F 20260206/260204230034 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |